Inhibrx Biosciences, Inc. (INBX)
84.52
+4.24
(+5.28%)
USD |
NASDAQ |
Nov 06, 16:00
84.95
+0.43
(+0.51%)
After-Hours: 20:00
Inhibrx Biosciences Market Cap : 1.243B for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.243B |
| November 05, 2026 | 1.181B |
| November 04, 2026 | 1.276B |
| November 03, 2026 | 1.193B |
| November 02, 2026 | 1.061B |
| October 30, 2026 | 1.056B |
| October 29, 2026 | 1.083B |
| October 28, 2026 | 1.078B |
| October 27, 2026 | 1.407B |
| October 26, 2026 | 1.303B |
| October 23, 2026 | 1.374B |
| October 22, 2026 | 1.428B |
| October 21, 2026 | 1.444B |
| October 20, 2026 | 1.402B |
| October 19, 2026 | 1.321B |
| October 16, 2026 | 1.321B |
| October 15, 2026 | 1.331B |
| October 14, 2026 | 1.254B |
| October 13, 2026 | 1.281B |
| October 12, 2026 | 1.332B |
| October 09, 2026 | 1.397B |
| October 08, 2026 | 1.364B |
| October 07, 2026 | 1.373B |
| October 06, 2026 | 1.374B |
| October 05, 2026 | 1.391B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.427B |
| October 01, 2026 | 1.440B |
| September 30, 2026 | 1.472B |
| September 29, 2026 | 1.542B |
| September 28, 2026 | 1.496B |
| September 25, 2026 | 1.465B |
| September 24, 2026 | 1.477B |
| September 23, 2026 | 1.476B |
| September 22, 2026 | 1.628B |
| September 21, 2026 | 1.648B |
| September 18, 2026 | 1.608B |
| September 17, 2026 | 1.540B |
| September 16, 2026 | 1.497B |
| September 15, 2026 | 1.553B |
| September 14, 2026 | 1.625B |
| September 11, 2026 | 1.607B |
| September 10, 2026 | 1.639B |
| September 09, 2026 | 1.660B |
| September 08, 2026 | 1.682B |
| September 04, 2026 | 1.782B |
| September 03, 2026 | 1.798B |
| September 02, 2026 | 1.838B |
| September 01, 2026 | 1.834B |
| August 31, 2026 | 1.864B |
| August 28, 2026 | 1.815B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 304.70M |
| Amgen, Inc. | 249.04B |
| Anika Therapeutics, Inc. | 194.72M |
| BioCryst Pharmaceuticals, Inc. | 1.970B |
| Imunon, Inc. | 3.942M |
Market Cap Related Metrics
| Price | 84.52 |
| Earnings Yield | -10.50% |